Morgan Stanley raises BlackRock Bitcoin ETF stake by 23%

Morgan Stanley increased its reported holding in BlackRock’s iShares Bitcoin Trust by about 23% to roughly 16.5 million shares in Q2.

Modestly positive bias for IBIT-linked sentiment, with limited near-term trading edge due to quarter-end reporting lag.

The article provides a concrete Q2 position increase, but 13F does not show trade timing, shorts, or whether the shares reflect proprietary capital versus managed accounts.

Morgan Stanley reported a new position in its own Morgan Stanley Bitcoin Trust (MSBT), which began trading in Q2.

Neutral-to-slightly positive for MSBT sentiment; direct price impact is uncertain because the reported stake is small versus IBIT.

The article discloses MSBT’s launch date and fee, plus a new reported share position, but the position value is far smaller than IBIT and 13F timing limits immediacy.

The filing shows Morgan Stanley added Solana exposure via Fidelity’s Solana fund, preceding its own Solana ETP launch under the MSOL ticker.

Slight positive bias for MSOL expectations, but the article does not provide MSOL holdings or flows.

The disclosed Solana-related positions are in third-party funds, and the MSOL product launch is after quarter-end, so the linkage to MSOL trading is indirect.

Morgan Stanley increased Ether exposure in BlackRock’s iShares Ethereum Trust ETF and Grayscale’s Ethereum staking mini ETF ahead of its own Ethereum ETP launch under MSSE.

Mild positive for MSSE sentiment, with limited immediate trading signal because the disclosed positions are in other issuers’ funds.

The article provides concrete Q2 increases in third-party Ether funds, but does not disclose MSSE holdings or same-quarter MSSE flows.

Morgan Stanley reduced its Coinbase share position by about 550,000 shares versus end of Q1, per the Q2 13F.

Slight negative sentiment for COIN, with low conviction due to reporting lag and lack of trade timing.

The article provides a directionally negative position change, but does not show why, at what price, or whether it was offset elsewhere.

Morgan Stanley cut its CleanSpark position by more than 3.1 million shares in Q2, according to the SEC filing.

Mild negative bias for CLSK sentiment; not a reliable near-term catalyst without trade timing.

This is a 13F quarter-end snapshot and does not indicate whether the reduction was driven by valuation, hedging, or portfolio rebalancing.

Morgan Stanley removed Bitfarms from its reported portfolio entirely, with no corresponding holding shown on June 30.

Slight negative sentiment for CIFR; limited trading edge due to quarter-end disclosure.

The article discloses disappearance from the quarter-end list but provides no transaction prices or rationale.